Hubbeling HG, Silverman EA, Michaud L, Alarcon Tomas A, Shouval R, Flynn J, Devlin S, Wijetunga NA, Tringale KT, Batlevi C, Dahi P, Giralt S, Lin R, Park J, Scordo M, Sauter C, Shah G, Hajj C, Salles G, Schoder H, Palomba ML, Perales MA, Joachim Y, Imber BS. Bridging Radiation Rapidly and Effectively Cytoreduces High-Risk Relapsed/Refractory Aggressive B Cell Lymphomas Prior to Chimeric Antigen Receptor T Cell Therapy , Transplant Cell Therapy, 29(4): 2023,259.e1-259.e10
Miao E, Eichholz JE, Lebow ES, Flynn J, Zhang Z, Walch H, Hubbeling HG, Beal K, Moss NS, Yu K, Yang JT, Meng A, Kelly DW, Gomez DR, Rimner A, Schultz N, Drilon A, Imber BS, Pike LRG. Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib , Lung Cancer, 178: 2023,57-65
Hubbeling HG, Choudhury N, Flynn J, Zhang Z, Falcon C, Rusch VW, Park BJ, Ziv E, Shaverdian N, Gelblum DY, Shepherd AF, Simone CB, Wu AJ, Gomez DR, Drilon A, Rimner A Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ ROS1/ RET-Rearranged Lung Cancers , JCO Precision Oncology, 6: 2022,e2200024
Hubbeling HG, Silverman EA, Michaud L, Flynn J, Devlin S, Wijetunga NA, Alarcon Tomas A, Shouval R, Palomba ML, Batlevi C, Dahi P, Park J, Scordo M, Sauter C, Shah G, Schoder H, Perales MA, Hajj C, Joachim Y, Imber, BS Patterns of Relapse and Risk Reduction Following Tumor Debulking by Bridging Radiotherapy Prior to Chimeric Antigen Receptor T Cell Therapy in Non-Hodgkin Lymphoma , 62nd Annual American Society for Radiation Oncology Meeting, San Antonio, TX: 2022
Tringale KR, Behroze VA, Hubbeling HG, Hajj C, Yahalom J, Grommes C, Imber BS Outcomes and Failure Patterns for >500 Patients Treated for Primary CNS Lymphoma (PCNSL) , 62nd Annual American Society for Radiation Oncology Meeting, San Antonio, TX: 2022
Hubbeling HG, Silverman EA, Alarcon Tomas A, Tringale KR, Wijetunga NA, Hajj C, Mailankody S, Batlevi C, Dahi P, Giralt S, Lin R, Park J, Scordo M, Sauter C, Shah G, Perales MA, Palomba ML, Shouval R, Joachim Y, Imber BS. Radiotherapy for Relapse after Chimeric Antigen Receptor T Cell Therapy in
Hematologic Malignancies , 62nd Annual American Society for Radiation Oncology Meeting, San
Antonio, TX: 2022
Tringale KR, Hubbeling HG, Chino F, Hajj C, Yahalom J, Imber BS Trends in Use of and Medicare Spending on Short-Course Radiotherapy for Lymphomas From 2015 to 2019 , JAMA Health Forum, 3(7): 2022,e221815
Ma J, Daou R, Bou Eid J, Lee J, Fregonese B, El-Khoury J, Wijetunga NA, Hubbeling HG, Tringale KR, Lebow ES, Imber BS, Yahalom J, Hajj C The Role of Radiation Therapy in the Treatment of Primary Hepatic Lymphomas , European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark: 2022
Hubbeling HG, Imber BS, Wijetunga NA, Tringale KR, Hajj C, Yahalom J Irradiating the Spleen for non-Hodgkin Lymphoma: Efficacy and Tolerance , European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark: 2022
Tringale KR, Grommes C, Behroze VA, Hubbeling HG, Wijetunga NA, Hajj C, Yahalom J, Imber BS Patterns of Failure in Primary CNS Lymphoma: the MSKCC Experience from 2004-2018 , European Society of Radiation Oncology Annual Meeting 2022, Copenhagen, Denmark: 2022
